Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics. Read more about cookies

Support us
Support us
  • Home
  • Roger Brüggemann

Roger Brüggemann

Researcher
 
 

Publications

234 publications in total

  • In vitro and clinical data demonstrate negligible risk of drug–drug interactions with opelconazole, a novel inhaled antifungal agent

    • dec. 2025
    • Lindsey M.R., Cass, et al
    • Journal of Antimicrobial Chemotherapy

  • Pharmacokinetics and Pharmacodynamics of Fosravuconazole, Itraconazole, and Hydroxyitraconazole in Sudanese Patients With Eumycetoma

    • sep. 2025
    • Wan Yu, Chu, et al
    • The Journal of infectious diseases

  • Classifying patients with invasive fungal disease

    • sep. 2025
    • Mehmet, Ergün, et al
    • Journal of Antimicrobial Chemotherapy

  • Population pharmacokinetics and optimized dosing of cefuroxime in critically ill patients

    • sep. 2025
    • Jaap W.A., Mouton, et al
    • British journal of clinical pharmacology

  • Antifungal Use in Immunocompromised Children in Europe

    • aug. 2025
    • Elisavet, Chorafa, et al
    • Journal of pediatric hematology/oncology
View all publications